https://www.verattia.com/ 2026-06-10 weekly 1.0 https://www.verattia.com/og-image.png Verattia: Doctor-led claim-risk review Doctor-led claim-risk review for UK pharmacy, aesthetics and consumer-health brands. https://www.verattia.com/about 2026-06-10 monthly 0.8 https://www.verattia.com/og-image.png About Dr Borna Farzaneh, Founding Director of Verattia Ltd Dr Borna Farzaneh, MBBS, GMC 7835999. Founding Director of Verattia Ltd. https://www.verattia.com/insights 2026-06-10 weekly 0.9 https://www.verattia.com/og-image.png Verattia Insights and Rulings Watch Doctor-led notes on UK ASA, MHRA and GPhC rulings. https://www.verattia.com/insights/glp1-private-prescriber-funnels-2026-05 2026-06-10 monthly 0.8 https://www.verattia.com/og-image.png Three upheld rulings in a day against one GLP-1 prescriber Paid posters in Mounjaro support groups, posing as customers. Doctor-led note. https://www.verattia.com/insights/gulp1-supplement-name-ruling-2026-06 2026-06-10 monthly 0.8 https://www.verattia.com/og-image.png A supplement called GuLP-1: the ASA decided the name was a claim Upheld 6 May 2026. Unauthorised weight-loss claims and a comparison set against an injection pen. Doctor-led note. https://www.verattia.com/insights/cap-1212-after-the-2025-enforcement-notice 2026-06-10 monthly 0.8 https://www.verattia.com/og-image.png CAP 12.12 after the 2025 Enforcement Notice Line-by-line read of how ASA, MHRA and GPhC now jointly frame promotion of POMs. https://www.verattia.com/privacy 2026-06-10 yearly 0.3 https://www.verattia.com/terms 2026-06-10 yearly 0.3 https://www.verattia.com/cookies 2026-06-10 yearly 0.3